Page last updated: 2024-08-21

aminoimidazole carboxamide and Age-Related Memory Disorders

aminoimidazole carboxamide has been researched along with Age-Related Memory Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Y; Li, M; Li, MZ; Liu, BJ; Shi, FX; Sun, DS; Tian, Q; Wang, JZ; Wang, L; Xu, WQ; Zhou, XW1
Chai, DM; Du, LL; Li, XH; Liu, LB; Liu, R; Wang, JZ; Wu, K; Zhang, FC; Zhang, HB; Zhao, LN; Zhou, XW1
Kim, DM; Leem, YH1
Dash, PK; Hill, JL; Hylin, MJ; Kobori, N; Moore, AN; Rozas, NS; Zhao, J1

Other Studies

4 other study(ies) available for aminoimidazole carboxamide and Age-Related Memory Disorders

ArticleYear
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
    Molecular neurobiology, 2018, Volume: 55, Issue:6

    Topics: Adenylate Kinase; Aging; Alzheimer Disease; Aminoimidazole Carboxamide; Animals; Cannabinoids; Enzyme Activation; Gene Deletion; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Phosphorylation; Receptor, Cannabinoid, CB2; Resveratrol; Ribonucleotides; Signal Transduction; tau Proteins

2018
AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 43, Issue:3

    Topics: Adenylate Kinase; Alzheimer Disease; Aminoimidazole Carboxamide; Animals; Caspase 3; Disease Models, Animal; Hippocampus; Hypoglycemic Agents; Male; Memory Disorders; Phosphorylation; Rats; Rats, Sprague-Dawley; Ribonucleotides; Spatial Memory; Streptozocin; tau Proteins

2015
Chronic stress-induced memory deficits are reversed by regular exercise via AMPK-mediated BDNF induction.
    Neuroscience, 2016, Jun-02, Volume: 324

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Exercise Therapy; Hippocampus; Male; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Neurogenesis; Nootropic Agents; Restraint, Physical; Ribonucleotides; Running; Stress, Psychological

2016
Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome.
    Journal of neurochemistry, 2016, Volume: 139, Issue:1

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain Injuries, Traumatic; Enzyme Activators; Hippocampus; Male; Maze Learning; Memory Disorders; Metformin; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nootropic Agents; Parietal Lobe; Phosphorylation; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribonucleotides

2016